LLOBF
Lloyds Banking Group plc
$2.00
0.00%
No data for this timeframe.
Vol
SEC Reports20
Recent Activity
Jun 5, 2026
SEC
Lloyds Banking Group plc disclosed the purchase of 5,000,000 of its own ordinary shares on June 5, 2026, as part of an e
6-K — Impact 2/10
Jun 5, 2026
SEC
Lloyds Banking Group plc repurchased 5,000,000 ordinary shares on 22 May 2026 at a volume-weighted average price of 99.5
6-K — Impact 2/10
Jun 5, 2026
SEC
Lloyds Banking Group filed a block admission application for 500,000,000 ordinary shares to be issued under employee sha
6-K — Impact 2/10
Analyst Ratings
4Strong Buy
12Buy
4Hold
2Sell
0Strong Sell
Latest Reports
No institutional holding data available yet. Data is sourced from 13F filings which are filed quarterly.
No insider trading data available yet. Insider transactions are collected from SEC Form 4 filings.
20 SEC filing reports analyzed. Sentiment: 0 bullish, 0 bearish, 0 mixed, 20 neutral. Avg impact: 2.0/10.
NEUTRAL
6-K
2/10
Lloyds Banking Group plc disclosed the purchase of 5,000,000 of its own ordinary shares on June 5, 2
Jun 5, 2026
NEUTRAL
6-K
2/10
Lloyds Banking Group plc repurchased 5,000,000 ordinary shares on 22 May 2026 at a volume-weighted a
Jun 5, 2026
NEUTRAL
6-K
2/10
Lloyds Banking Group filed a block admission application for 500,000,000 ordinary shares to be issue
Jun 5, 2026
NEUTRAL
6-K
2/10
Lloyds Banking Group plc disclosed the purchase of 2,500,000 ordinary shares on June 4, 2026, as par
Jun 4, 2026
NEUTRAL
6-K
2/10
Lloyds Banking Group disclosed the purchase of 10,000,000 ordinary shares on June 3, 2026, at a volu
Jun 3, 2026
NEUTRAL
6-K
2/10
Lloyds Banking Group plc repurchased 7,500,000 ordinary shares on 2 June 2026 at a volume-weighted a
Jun 2, 2026
NEUTRAL
6-K
2/10
Lloyds Banking Group disclosed the purchase of 10 million ordinary shares on June 1, 2026, at a volu
Jun 1, 2026
NEUTRAL
6-K
3/10
Lloyds Banking Group plc disclosed the repurchase of 7,853,706 ordinary shares on 29 May 2026 at a v
May 29, 2026
NEUTRAL
6-K
2/10
Lloyds Banking Group filed a routine 6-K disclosing its total voting rights as of 29 May 2026: 58,38
May 29, 2026
NEUTRAL
6-K
2/10
Lloyds Banking Group filed a 6-K reporting that Chief Legal Officer & Company Secretary Kate Cheetha
May 29, 2026
NEUTRAL
6-K
2/10
Lloyds Banking Group plc filed a Form 6-K on 28 May 2026 reporting the purchase of 7,746,541 ordinar
May 28, 2026
NEUTRAL
6-K
2/10
Lloyds Banking Group purchased 5,000,000 ordinary shares on May 27, 2026, as part of its existing bu
May 27, 2026
NEUTRAL
6-K
2/10
Lloyds Banking Group plc repurchased 4,000,000 ordinary shares on 26 May 2026 at a volume-weighted a
May 26, 2026
NEUTRAL
6-K
2/10
Lloyds Banking Group filed a 6-K reporting that a non-executive director, Catherine Woods, and a per
May 26, 2026
NEUTRAL
6-K
2/10
Lloyds Banking Group plc announced the repurchase of 15,675,080 ordinary shares on 18 May 2026 at a
May 18, 2026
NEUTRAL
6-K
2/10
Lloyds Banking Group announced that all 26 resolutions at its 2026 Annual General Meeting were passe
May 14, 2026
NEUTRAL
6-K
2/10
Lloyds Banking Group purchased 11.85 million ordinary shares at an average price of 94.45 pence as p
May 13, 2026
NEUTRAL
25-NSE
2/10
The NYSE filed a Form 25-NSE to delist and deregister Lloyds Banking Group's 1.627% Senior Callable
May 12, 2026
NEUTRAL
6-K
2/10
Lloyds Banking Group repurchased 16.6 million ordinary shares at an average price of 98.78 pence as
May 11, 2026
NEUTRAL
6-K
2/10
Lloyds Banking Group plc disclosed the purchase of 20 million ordinary shares on May 7, 2026 as part
May 7, 2026
No press releases analyzed yet. Press releases are collected from GlobeNewsWire and analyzed by the LLM pipeline.
Historical analyst distribution: 73% buy across 22 analysts — 4 strong buy, 12 buy, 4 hold, 2 sell, 0 strong sell. No current recommendation available.
Monthly Consensus History
| Period | Strong Buy | Buy | Hold | Sell | Strong Sell | Buy % | Distribution |
|---|---|---|---|---|---|---|---|
| Jun 1, 2026 | 4 | 12 | 4 | 2 | 0 | 73% | |
| May 1, 2026 | 4 | 13 | 4 | 2 | 0 | 74% | |
| Apr 1, 2026 | 3 | 12 | 6 | 2 | 0 | 65% | |
| Mar 1, 2026 | 3 | 12 | 6 | 2 | 0 | 65% | |
| Feb 1, 2026 | 3 | 12 | 7 | 0 | 1 | 65% | |
| Jan 1, 2026 | 3 | 12 | 7 | 0 | 0 | 68% |
Strong BuyBuyHoldSellStrong Sell
No congressional trading data available for this ticker. Data is sourced from Senate and House financial disclosure filings.
No Reddit sentiment data available yet. Sentiment is analyzed from Reddit investment communities on a rolling basis.
No events recorded for this ticker. Events include FDA actions, clinical trials, enforcement actions, and market-moving developments.